IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States

Journal of Clinical Microbiology

Volumn 49, Issue 12, 2011, Pages 4239-4245

  Limbago, Brandi M ^a   Rasheed, J Kamile ^a   Anderson, Karen F ^a   Zhu, Wenming ^a   Kitchel, Brandon ^a   Watz, Nancy ^b   Munro, Susan ^b   Gans, Hayley ^b   Banaei, Niaz ^b   Kallen, Alex J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IBUPROFEN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; MINOCYCLINE; PARACETAMOL; POLYMYXIN; QUINOLONE DERIVATIVE; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSISTED VENTILATION; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EAR INFECTION; FEMALE; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LUNG DISEASE; MALE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MOLECULAR TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 82455186910     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05297-11     Document Type: Article

References (45)

1. Arakawa, Y., et al. 1995. A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob. Agents Chemother. 39:1612-1615.
2. Bennett, J. W., M. L. Herrera, J. S. Lewis II, B. W. Wickes, and J. H. Jorgensen. 2009. KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob. Agents Chemother. 53:292-294.
3. Boucher, H. W., et al. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
4. Bradford, P. A., et al. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569. (Pubitemid 27098404)
5. Bratu, S., et al. 2007. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975. (Pubitemid 46452064)
6. Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238.
7. Centers for Disease Control and Prevention. 2010. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:750.
8. Centers for Disease Control and Prevention. 2009. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb. Mortal. Wkly. Rep. 58:256-260.
9. Centers for Disease Control and Prevention. 2010. Update: detection of a Verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae - United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:1212.
10. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility: tests for bacteria that grow aerobically; approved standard, 8th ed. M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Ellington, M. J., J. Kistler, D. M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321-322. (Pubitemid 47072076)
15. Garza-Ramos, U., et al. 2008. Metallo-β-lactamase gene blaIMP-15 in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob. Agents Chemother. 52:2943-2946.
16. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
17. Gupta, N., B. M. Limbago, J. B. Patel, and A. Kallen. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention strategies. Clin. Infect. Dis. 53:60-67.
18. Hanson, N. D., A. Hossain, L. Buck, E. S. Moland, and K. S. Thomson. 2006. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob. Agents Chemother. 50:2272-2273. (Pubitemid 43807565)
19. Kallen, A. J., and A. Srinivasan. 2010. Current epidemiology of multidrug-resistant gram-negative bacilli in the United States. Infect. Control Hosp. Epidemiol. 31(Suppl. 1):S51-S54.
20. Kim, S. Y., S. G. Hong, E. S. Moland, and K. S. Thomson. 2007. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory. J. Clin. Microbiol. 45:2798-2801.
21. Kitchel, B., et al. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53:3365-3370.
22. Kitchel, B., D. R. Sundin, and J. B. Patel. 2009. Regional dissemination of KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 53:4511-4513.
23. Laupland, K. B., et al. 2005. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J. Infect. Dis. 192:1606-1612. (Pubitemid 41504696)
24. Limbago, B. M., J. K. Rasheed, K. F. Anderson, W. Zhu, and A. J. Kallen. 2010. Recognition of NDM-1 among Enterobacteriaceae in the United States, abstr. C1-675d. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
25. Lolans, K., A. M. Queenan, K. Bush, A. Sahud, and J. P. Quinn. 2005. First nosocomial outbreak of Pseudomonas aeruginosa producing an integronborne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49:3538-3540. (Pubitemid 41060613)
26. Luzzaro, F., et al. 2004. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48:648-650. (Pubitemid 38141736)
27. Migliavacca, R., et al. 2002. Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J. Clin. Microbiol. 40:4388-4390. (Pubitemid 35285853)
28. Miriagou, V., et al. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300. (Pubitemid 36368588)
29. Mochon, A. B., et al. 2011. New Delhi metallo-β-lactamase (NDM-1) producing Klebsiella pneumoniae: a case report and laboratory detection strategies. J. Clin. Microbiol. 49:1667-1670.
30. Osano, E., et al. 1994. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78. (Pubitemid 24018160)
31. Patel, G., S. Huprikar, S. H. Factor, S. G. Jenkins, and D. P. Calfee. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29:1099-1106.
32. Patel, J. B., J. K. Rasheed, and B. Kitchel. 2009. Carbapenemases in Enterobacteriaceae: activity, epidemiology, and laboratory detection. Clin. Microbiol. Newsl. 31:55-62.
33. Poirel, L., P. Nordmann, E. Lagrutta, T. Cleary, and L. S. Munoz-Price. 2010. Emergence of KPC-producing Pseudomonas aeruginosa in the United States. Antimicrob. Agents Chemother. 54:3072.
34. Poirel, L., J. D. Pitout, and P. Nordmann. 2007. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2:501-512. (Pubitemid 47578214)
35. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458.
36. Quinones-Falconi, F., et al. 2010. Emergence of Pseudomonas aeruginosa strains producing metallo-beta-lactamases of the IMP-15 and VIM-2 types in Mexico. Clin. Microbiol. Infect. 16:126-131.
37. Robledo, I. E., et al. 2010. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob. Agents Chemother. 54:1354-1357.
38. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
39. Tibbetts, R., J. G. Frye, J. Marschall, D. Warren, and W. Dunne. 2008. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J. Clin. Microbiol. 46:3080-3083.
40. Vatopoulos, A. 2008. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill. 13:8023.
41. Villegas, M. V., et al. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553-1555. (Pubitemid 46586851)
42. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallobeta-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
43. Watanabe, M., S. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:147-151.
44. Yan, J. J., et al. 2001. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.
45. Yigit, H., et al. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161. (Pubitemid 32230996)